Incidence and Mortality of Lung Cancer Among Never Smokers in Relationship to Secondhand Smoking: Findings From the PLCO Trial.


Journal

Clinical lung cancer
ISSN: 1938-0690
Titre abrégé: Clin Lung Cancer
Pays: United States
ID NLM: 100893225

Informations de publication

Date de publication:
09 2020
Historique:
received: 19 08 2019
revised: 15 03 2020
accepted: 03 04 2020
pubmed: 12 5 2020
medline: 12 10 2021
entrez: 12 5 2020
Statut: ppublish

Résumé

To assess the impact of secondhand smoking on the incidence and mortality of lung cancer among never smokers enrolled onto the Prostate, Lung, Colorectal, and Ovary (PLCO) study. Deidentified data sets from the PLCO study were accessed and never smokers who completed the supplementary questionnaire's questions related to history of exposure to secondhand smoking were included in the current study. Multivariate Cox regression analysis was conducted to evaluate the impact of adulthood and childhood secondhand smoking on lung cancer incidence and mortality. A total of 49,569 participants were included in the current analysis. Using multivariate Cox regression analysis, participants with secondhand smoking most of their work time had a higher risk of lung cancer diagnosis (hazard ratio, 2.038; 95% confidence interval, 1.313-3.164; P = .002). Likewise, participants with secondhand smoking most of their adult living time had a higher risk of lung cancer diagnosis (hazard ratio, 1.809; 95% confidence interval, 1.161-2.819; P = .009). Moreover, participants with secondhand smoking most of the adult time had a higher risk of death from lung cancer (hazard ratio, 1.925; 95% confidence interval, 1.035-3.575; P = .038). Participants with secondhand smoking most of the adult time were also more likely to have had hypertension (P < .001), diabetes mellitus (P < .001), heart attack (P < .001), stroke (P = .028), chronic bronchitis (P < .001), and emphysema (P < .001). Never smokers with a history of adult secondhand smoking had a higher probability of a subsequent diagnosis of lung cancer. Likewise, never smokers with a history of adult secondhand smoking were more likely to die from lung cancer.

Identifiants

pubmed: 32389507
pii: S1525-7304(20)30108-X
doi: 10.1016/j.cllc.2020.04.009
pii:
doi:

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-420.e2

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Omar Abdel-Rahman (O)

Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada; Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: omar.abdelsalam@ahs.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH